Gentian Diagnostics ASA (OSL: GENT)
50.00
-2.50 (-4.76%)
Aug 30, 2024, 4:27 PM CET
Gentian Diagnostics ASA Revenue
Gentian Diagnostics ASA had revenue of 38.26M NOK in the quarter ending June 30, 2024, with 5.81% growth. This brings the company's revenue in the last twelve months to 151.51M, up 22.63% year-over-year. In the year 2023, Gentian Diagnostics ASA had annual revenue of 142.35M with 27.18% growth.
Revenue (ttm)
151.51M
Revenue Growth
+22.63%
P/S Ratio
5.07
Revenue / Employee
2.61M
Employees
58
Market Cap
771.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 142.35M | 30.42M | 27.18% |
Dec 31, 2022 | 111.92M | 11.91M | 11.91% |
Dec 31, 2021 | 100.01M | 21.13M | 26.78% |
Dec 31, 2020 | 78.88M | 23.50M | 42.43% |
Dec 31, 2019 | 55.38M | 9.56M | 20.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Navamedic ASA | 543.49M |